For over a decade, Pappas Ventures has been nurturing promising life sciences ideas and delivering superior results to investors and entrepreneurs alike.

Portfolio Highlights

• CoLucid announces $25 million Series B financing for advancement of first-in-class migraine compound
  July 1, 2008
• Methylgene announces the initiation of a Phase 2 trial of MGCD0103
  June 25, 2008
• Plexxikon announces preclinical data demonstrating dramatic improvement in key symptoms of polycystic kidney disease
  May 21, 2008

Pappas Ventures News

• Jeff Collins was elected to a 3-year term on the Board of Directors of NCBIO at its annual meeting, in Winston-Salem, NC
  May 19, 2008
• Art Pappas to participate at Foundation Sante Biotechnology Conference at Samos, Greece
  July 11, 2008
• Arthur Klausner to speak at the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) in Boston, MA
  August 4-7, 2008